With more than 40 years of experience in normal human cells and best-in-class cGMP compliance, Lonza (headquarter Basel, CH) is the industry leader in development, manufacturing and testing services for cell-based therapeutics. Lonza Netherlands was founded in 2005 as a Contract Manufacturing Organisation in Europe for Cell Therapy and Regenerative Medicine. CMO services range from thorough transfer of technologies, QP release of products for the EU market, controlled temperature transportation to process development, including cell culture scale-up know-how and manufacturing of Advanced Therapeutic Medicinal Products. Today, Lonza Netherlands is involved in projects with international consortia from academia as well as industrial partners to bridge preclinical development to clinical manufacturing. Lonza’s (LON) main task in EVPRO is to advice the partners on GMP-compliant manufacturing, isolation, purification and formulation for the industrial production of MSC-EVs. As soon as a cutting-edge proprietary manufacturing system is realized – probably towards the end of the project – Lonza will bring the system to an industrial environment.
Contact
Dr. Birgit Nelsen-Salz
Phone +49 221 991990
birgit.nelsen-salz@lonza.com
https://www.lonza.com/about-lonza/company-profile/locations-worldwide/geleen-the-netherlands.aspx
Dr.Bart van Dijk
Phone +31 43 35 09910
bart.vandijk@lonza.com